Clinical Evidence
Evaluation of Glucose Management Software in Critically Ill Patients with Hyperglycemic Crises
Objective
This retrospective review examines the safety and effectiveness of a computerized glucose management system (EndoTool) for critically ill diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic states (HHS) patients.
Setting
1,041-bed non-profit tertiary care and academic medical center.
Results
- With an initial blood glucose >300 mg/dL, mean rate of blood glucose reduction was 87 mg/dL/hour, with 84% of patients achieving a rate of at least 50 mg/dL/hour.
- Incidence of severe hypoglycemia <40 mg/dL was 0.17% of blood glucose measurements and incidence of hypoglycemia <60 mg/dL was 0.79% of blood glucose measurements.
Conclusions
Management of continuous intravenous insulin infusion utilizing a computerized glucose management system (EndoTool) is both safe and effective at lowering blood glucose in DKA and HHS patients, with very minimal risk of hypoglycemia.
References
Authors
Maresa Glass, PharmD, BCPS; Kevin Ferguson, PharmD, BCPS; Mark Rumbak, MD.
Source
Presented at Society of Critical Care Medicine Critical Care Congress. Published in Critical Care Medicine, Volume 42, Issue 12, pA1441.
Year
2014
Related posts
Clinical Evidence
Achieving Optimal Glucose Control in Critical Care Units at Atrium Health
Achieving Optimal Glucose Control in Critical Care Units at Atrium Health
Clinical Evidence
Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings
Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings
Clinical Evidence
EndoTool IV Leads to Over 55% Fewer Blood Glucose Checks With an 84% Decrease in Hypoglycemic Events at UPMC
EndoTool IV Leads to Over 55% Fewer Blood Glucose Checks With an 84% Decrease in Hypoglycemic Events at UPMC
Get in Touch
Ready to get started?
"*" indicates required fields